Diagnostic value of urine sCD163 levels for sepsis and relevant acute kidney injury: A prospective study

BMC Nephrology

Volumn 13, Issue 1, 2012, Pages

  Su, Longxiang ^a,b,d   Feng, Lin ^c   Liu, Changting ^d   Jiang, Zhaoxu ^a,b,d   Li, Ming ^a,b,d   Xiao, Kun ^a,d   Yan, Peng ^a   Jia, Yanhong ^d   Feng, Dan ^d   Xie, Lixin ^a,d  

^a CHINESE PLA GENERAL HOSPITAL   (China)

^b NANKAI UNIVERSITY   (China)

^c Department of Respiratory Medicine   (China)

^d CHINESE PLA GENERAL HOSPITAL   (China)

Author keywords

Acute kidney injury (AKI); Prognosis; Sepsis; Soluble CD163 (sCD163); Systemic inflammatory response syndrome (SIRS); Urine

Indexed keywords

CD163 ANTIGEN; SOLUBLE CD163 ANTIGEN; UNCLASSIFIED DRUG;

ACUTE KIDNEY FAILURE; ADULT; ARTICLE; BLOOD LEVEL; CONTROLLED STUDY; DIAGNOSTIC VALUE; DISEASE SEVERITY; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; PROGNOSIS; PROSPECTIVE STUDY; SENSITIVITY AND SPECIFICITY; SEPSIS; SYSTEMIC INFLAMMATORY RESPONSE SYNDROME; URINE LEVEL;

ACUTE KIDNEY INJURY; ADULT; AGED; ANTIGENS, CD; ANTIGENS, DIFFERENTIATION, MYELOMONOCYTIC; BIOLOGICAL MARKERS; FEMALE; HUMANS; MALE; MIDDLE AGED; PROSPECTIVE STUDIES; RECEPTORS, CELL SURFACE; SEPSIS; SYSTEMIC INFLAMMATORY RESPONSE SYNDROME;

EID: 84866557623     PISSN: None     EISSN: 14712369     Source Type: Journal    
DOI: 10.1186/1471-2369-13-123     Document Type: Article

References (41)

1. Incidence, risk factors, and outcome of severe sepsis and septic shock in adults. A multicenter prospective study in intensive care units. French ICU Group for Severe Sepsis. Brun-Buisson C, Doyon F, Carlet J, Dellamonica P, Gouin F, Lepoutre A, Mercier JC, Offenstadt G, Regnier B, JAMA 1995 274 12 968 974 10.1001/jama.1995.03530120060042 7674528
2. CD163: a regulated hemoglobin scavenger receptor with a role in the anti-inflammatory response. Moestrup SK, Moller HJ, Ann Med 2004 36 5 347 354 10.1080/07853890410033171 15478309 (Pubitemid 39233102)
3. CD163: a signal receptor scavenging haptoglobin-hemoglobin complexes from plasma. Graversen JH, Madsen M, Moestrup SK, Int J Biochem Cell Biol 2002 34 4 309 314 10.1016/S1357-2725(01)00144-3 11854028 (Pubitemid 34164272)
4. Soluble CD163 inhibits phorbol ester-induced lymphocyte proliferation. Hogger P, Sorg C, Biochem Biophys Res Commun 2001 288 4 841 843 10.1006/bbrc.2001.5845 11688984 (Pubitemid 33140958)
5. Oxidative stress and 8-iso-prostaglandin F(2alpha) induce ectodomain shedding of CD163 and release of tumor necrosis factor-alpha from human monocytes. Timmermann M, Hogger P, Free Radic Biol Med 2005 39 1 98 107 10.1016/j.freeradbiomed.2005.02.031 15925282 (Pubitemid 40733120)
6. Clinical Significance of Soluble Hemoglobin Scavenger Receptor CD163 (sCD163) in Sepsis, a Prospective Study. Lin Feng XZ, Long-Xiang S, Dan F, Yan-Hong J, Li-Xin X, PLoSOne 2012 7 7 38400
7. New immunological serum markers in bacteraemia: anti-inflammatory soluble CD163, but not proinflammatory high mobility group-box 1 protein, is related to prognosis. Gaini S, Pedersen SS, Koldkaer OG, Pedersen C, Moestrup SK, Moller HJ, Clin Exp Immunol 2008 151 3 423 431 10.1111/j.1365-2249.2007.03586.x 18190604 (Pubitemid 351160736)
8. Macrophage serum markers in pneumococcal bacteremia: Prediction of survival by soluble CD163. Moller HJ, Moestrup SK, Weis N, Wejse C, Nielsen H, Pedersen SS, Attermann J, Nexo E, Kronborg G, Crit Care Med 2006 34 10 2561 2566 10.1097/01.CCM.0000239120.32490.AB 16915112 (Pubitemid 44413053)
9. Changes in fat mass correlate with changes in soluble sCD163, a marker of mature macrophages, in patients with CKD. Axelsson J, Moller HJ, Witasp A, Qureshi AR, Carrero JJ, Heimburger O, Barany P, Alvestrand A, Lindholm B, Moestrup SK, et al. American journal of kidney diseases: the official journal of the National Kidney Foundation 2006 48 6 916 925 10.1053/j.ajkd.2006.08.022 (Pubitemid 44895371)
10. Role of free hemoglobin in 8-iso prostaglandin F2-alpha synthesis in chronic renal failure and its impact on CD163-Hb scavenger receptor and on coronary artery endothelium. Simoni J, Simoni G, Griswold JA, Moeller JF, Tsikouris JP, Khanna A, Roongsritong C, Wesson DE, ASAIO J 2006 52 6 652 661 10.1097/01.mat.0000235282.89757.9f 17117055 (Pubitemid 44784567)
11. Definitions for sepsis and organ failure and guidelines for the use of innovative therapies in sepsis. The ACCP/SCCM Consensus Conference Committee. American College of Chest Physicians/Society of Critical Care Medicine. Bone RC, Balk RA, Cerra FB, Dellinger RP, Fein AM, Knaus WA, Schein RM, Sibbald WJ, Chest 1992 101 6 1644 1655 10.1378/chest.101.6.1644 1303622
12. 2001 SCCM/ESICM/ACCP/ATS/SIS International Sepsis Definitions Conference. Levy MM, Fink MP, Marshall JC, Abraham E, Angus D, Cook D, Cohen J, Opal SM, Vincent JL, Ramsay G, Crit Care Med 2003 31 4 1250 1256 10.1097/01.CCM. 0000050454.01978.3B 12682500 (Pubitemid 36444440)
13. Back-calculating baseline creatinine with MDRD misclassifies acute kidney injury in the intensive care unit. Pickering JW, Endre ZH, Clinical journal of the American Society of Nephrology: CJASN 2010 5 7 1165 1173 10.2215/CJN.08531109 20498242
14. Evaluation of trial outcomes in acute kidney injury by creatinine modeling. Pickering JW, Frampton CM, Endre ZH, Clinical journal of the American Society of Nephrology: CJASN 2009 4 11 1705 1715 10.2215/CJN.00820209 19729431
15. Acute Kidney Injury Network: report of an initiative to improve outcomes in acute kidney injury. Mehta RL, Kellum JA, Shah SV, Molitoris BA, Ronco C, Warnock DG, Levin A, Crit Care 2007 11 2 31 10.1186/cc5713 17331245 (Pubitemid 46604959)
16. Acute renal failure in critically ill patients: a multinational, multicenter study. Uchino S, Kellum JA, Bellomo R, Doig GS, Morimatsu H, Morgera S, Schetz M, Tan I, Bouman C, Macedo E, et al. JAMA 2005 294 7 813 818 10.1001/jama.294.7.813 16106006 (Pubitemid 41175724)
17. Clinical characteristics of patients developing ARF due to sepsis/systemic inflammatory response syndrome: results of a prospective study. Yegenaga I, Hoste E, Van Biesen W, Vanholder R, Benoit D, Kantarci G, Dhondt A, Colardyn F, Lameire N, American journal of kidney diseases: the official journal of the National Kidney Foundation 2004 43 5 817 824 10.1053/j.ajkd.2003.12.045 (Pubitemid 38529619)
18. Acute renal failure in patients with sepsis in a surgical ICU: predictive factors, incidence, comorbidity, and outcome. Hoste EA, Lameire NH, Vanholder RC, Benoit DD, Decruyenaere JM, Colardyn FA, Journal of the American Society of Nephrology: JASN 2003 14 4 1022 1030 10.1097/01.ASN.0000059863.48590.E9 12660337 (Pubitemid 36359284)
19. Urinary biomarkers in septic acute kidney injury. Bagshaw SM, Langenberg C, Haase M, Wan L, May CN, Bellomo R, Intensive Care Med 2007 33 7 1285 1296 10.1007/s00134-007-0656-5 17487471 (Pubitemid 47036892)
20. Mediators of inflammation in acute kidney injury. Akcay A, Nguyen Q, Edelstein CL, Mediators Inflamm 2009 2009 137072 20182538
21. A central role for free heme in the pathogenesis of severe sepsis. Larsen R, Gozzelino R, Jeney V, Tokaji L, Bozza FA, Japiassu AM, Bonaparte D, Cavalcante MM, Chora A, Ferreira A, et al. Sci Transl Med 2010 2 51 51ra71 10.1126/scitranslmed.3001118 20881280
22. Receptor targeting of hemoglobin mediated by the haptoglobins: roles beyond heme scavenging. Nielsen MJ, Moestrup SK, Blood 2009 114 4 764 771 10.1182/blood-2009-01-198309 19380867
23. Biomarker discovery with SELDI-TOF MS in human urine associated with early renal injury: evaluation with computational analytical tools. Vanhoutte KJ, Laarakkers C, Marchiori E, Pickkers P, Wetzels JF, Willems JL, van den Heuvel LP, Russel FG, Masereeuw R, Nephrology, dialysis, transplantation: official publication of the European Dialysis and Transplant Association-European Renal Association 2007 22 10 2932 2943 10.1093/ndt/gfm170 (Pubitemid 350093415)
24. Regulation of scavenger receptor CD163 expression in human monocytes and macrophages by pro- and antiinflammatory stimuli. Buechler C, Ritter M, Orso E, Langmann T, Klucken J, Schmitz G, J Leukoc Biol 2000 67 1 97 103 10648003 (Pubitemid 30046823)
25. Haptoglobin and CD163: captor and receptor gating hemoglobin to macrophage lysosomes. Madsen M, Graversen JH, Moestrup SK, Redox report: communications in free radical research 2001 6 6 386 388 10.1179/ 135100001101536490 11865982 (Pubitemid 34134333)
26. The macrophage scavenger receptor CD163 functions as an innate immune sensor for bacteria. Fabriek BO, van Bruggen R, Deng DM, Ligtenberg AJ, Nazmi K, Schornagel K, Vloet RP, Dijkstra CD, van den Berg TK, Blood 2009 113 4 887 892 10.1182/blood-2008-07-167064 18849484
27. Soluble haemoglobin scavenger receptor (sCD163) in patients with suspected community-acquired infections. Gaini S, Koldkjaer OG, Pedersen SS, Pedersen C, Moestrup SK, Moller HJ, APMIS 2006 114 2 103 111 10.1111/j.1600-0463.2006.apm-341.x 16519746 (Pubitemid 43356920)
28. Predictive value of soluble haemoglobin scavenger receptor CD163 serum levels for survival in verified tuberculosis patients. Knudsen TB, Gustafson P, Kronborg G, Kristiansen TB, Moestrup SK, Nielsen JO, Gomes V, Aaby P, Lisse I, Moller HJ, et al. Clin Microbiol Infect 2005 11 9 730 735 10.1111/j.1469-0691. 2005.01229.x 16104988 (Pubitemid 41167339)
29. Sepsis as a cause and consequence of acute kidney injury: Program to Improve Care in Acute Renal Disease. Mehta RL, Bouchard J, Soroko SB, Ikizler TA, Paganini EP, Chertow GM, Himmelfarb J, Renal PICA, Intens Care Med 2011 37 2 241 248 10.1007/s00134-010-2089-9
30. Induction of kidney heme oxygenase-1 (HSP32) mRNA and protein by ischemia/reperfusion: possible role of heme as both promotor of tissue damage and regulator of HSP32. Maines MD, Mayer RD, Ewing JF, McCoubrey WK Jr, J Pharmacol Exp Ther 1993 264 1 457 462 8423544 (Pubitemid 23309236)
31. Induction of heme oxygenase in toxic renal injury: a protective role in cisplatin nephrotoxicity in the rat. Agarwal A, Balla J, Alam J, Croatt AJ, Nath KA, Kidney Int 1995 48 4 1298 1307 10.1038/ki.1995.414 8569092
32. Rhabdomyolysis and myohemoglobinuric acute renal failure. Zager RA, Kidney Int 1996 49 2 314 326 10.1038/ki.1996.48 8821813 (Pubitemid 26051819)
33. Albuminuria increases cystatin C excretion: implications for urinary biomarkers. Nejat M, Hill JV, Pickering JW, Edelstein CL, Devarajan P, Endre ZH, Nephrology, dialysis, transplantation: official publication of the European Dialysis and Transplant Association-European Renal Association 2011 Epub ahead of print
34. Different faces of the heme-heme oxygenase system in inflammation. Wagener FADTG, Volk HD, Willis D, Abraham NG, Soares MP, Adema GJ, Figdor CG, Pharmacol Rev 2003 55 3 551 571 10.1124/pr.55.3.5 12869663 (Pubitemid 37013215)
35. Heme: a novel inducer of MCP-1 through HO-dependent and HO-independent mechanisms. Kanakiriya SKR, Croatt AJ, Haggard JJ I Jr, Tang SS, Alam J, Nath KA, Am J Physiol-Renal 2003 28 (3 546 F554 (Pubitemid 36227917)
36. Heme protein-induced chronic renal inflammation: Suppressive effect of induced heme oxygenase-1. Nath KA, Vercellotti GM, Grande JP, Miyoshi H, Paya CV, Manivel JC, Haggard JJ, Croatt AJ, Payne WD, Alam J, Kidney Int 2001 59 1 106 117 10.1046/j.1523-1755.2001.00471.x 11135063 (Pubitemid 32055219)
37. Physiology and pathophysiology of heme: implications for kidney disease. Tracz MJ, Alam J, Nath KA, Journal of the American Society of Nephrology: JASN 2007 18 2 414 420 10.1681/ASN.2006080894 17229906 (Pubitemid 46193307)
38. Pathways of renal injury in systemic gram-negative sepsis. El-Achkar TM, Hosein M, Dagher PC, Eur J Clin Invest 2008 38 Suppl 2 39 44 18826480
39. Renal blood flow in sepsis. Langenberg C, Bellomo R, May C, Wan L, Egi M, Morgera S, Crit Care 2005 9 4 363 374 10.1186/cc3540 16137349
40. Renal blood flow in experimental septic acute renal failure. Langenberg C, Wan L, Egi M, May CN, Bellomo R, Kidney Int 2006 69 11 1996 2002 10.1038/sj.ki.5000440 16641923 (Pubitemid 43924263)
41. Urinary cystatin C is diagnostic of acute kidney injury and sepsis, and predicts mortality in the intensive care unit. Nejat M, Pickering JW, Walker RJ, Westhuyzen J, Shaw GM, Frampton CM, Endre ZH, Crit Care 2010 14 3 85 10.1186/cc9014 20459852